Arnon Nagler
Arnon Nagler
Professor of Medicine,Tel Aviv University
Verified email at sheba.health.gov.il
Title
Cited by
Cited by
Year
Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of …
S Slavin, A Nagler, E Naparstek, Y Kapelushnik, M Aker, G Cividalli, ...
Blood, The Journal of the American Society of Hematology 91 (3), 756-763, 1998
25161998
Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4
A Peled, I Petit, O Kollet, M Magid, T Ponomaryov, T Byk, A Nagler, ...
Science 283 (5403), 845-848, 1999
19841999
G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4
I Petit, M Szyper-Kravitz, A Nagler, M Lahav, A Peled, L Habler, ...
Nature immunology 3 (7), 687-694, 2002
16342002
The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34+ cells: role in transendothelial/stromal migration and …
A Peled, O Kollet, T Ponomaryov, I Petit, S Franitza, V Grabovsky, ...
Blood, The Journal of the American Society of Hematology 95 (11), 3289-3296, 2000
9412000
HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver
O Kollet, S Shivtiel, YQ Chen, J Suriawinata, SN Thung, MD Dabeva, ...
The Journal of clinical investigation 112 (2), 160-169, 2003
8262003
Comparative studies of human FcRIII-positive and negative natural killer cells.
A Nagler, LL Lanier, S Cwirla, JH Phillips
The Journal of Immunology 143 (10), 3183-3191, 1989
8261989
Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies
R Berger, R Rotem-Yehudar, G Slama, S Landes, A Kneller, M Leiba, ...
Clinical Cancer Research 14 (10), 3044-3051, 2008
7592008
Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy …
RZ Orlowski, A Nagler, P Sonneveld, J Bladé, R Hajek, A Spencer, ...
Journal of Clinical Oncology 25 (25), 3892-3901, 2007
7302007
Autologous transplantation and maintenance therapy in multiple myeloma
A Palumbo, F Cavallo, F Gay, F Di Raimondo, D Ben Yehuda, MT Petrucci, ...
New England Journal of Medicine 371 (10), 895-905, 2014
6922014
Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function
T Ponomaryov, A Peled, I Petit, RS Taichman, L Habler, J Sandbank, ...
The Journal of clinical investigation 106 (11), 1331-1339, 2000
6672000
CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow
A Avigdor, P Goichberg, S Shivtiel, A Dar, A Peled, S Samira, O Kollet, ...
Blood 103 (8), 2981-2989, 2004
5882004
Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation
S Slavin, E Naparstek, A Nagler, A Ackerstein, S Samuel, J Kapelushnik, ...
5191996
Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients
MJ Besser, R Shapira-Frommer, AJ Treves, D Zippel, O Itzhaki, ...
Clinical cancer research 16 (9), 2646-2655, 2010
5102010
Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results …
P Armand, A Nagler, EA Weller, SM Devine, DE Avigan, YB Chen, ...
Journal of clinical oncology 31 (33), 4199, 2013
4932013
Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older …
M Aoudjhane, M Labopin, NC Gorin, A Shimoni, T Ruutu, HJ Kolb, ...
Leukemia 19 (12), 2304-2312, 2005
4602005
Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease
F Locatelli, V Rocha, W Reed, F Bernaudin, M Ertem, S Grafakos, ...
Blood, The Journal of the American Society of Hematology 101 (6), 2137-2143, 2003
4572003
Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk …
C Schmid, M Labopin, A Nagler, M Bornhäuser, J Finke, A Fassas, ...
Journal of clinical oncology 25 (31), 4938-4945, 2007
4442007
Multicenter independent assessment of outcomes in chronic myeloid leukemia patients treated with imatinib
C Gambacorti-Passerini, L Antolini, FX Mahon, F Guilhot, M Deininger, ...
Journal of the National Cancer Institute 103 (7), 553-561, 2011
4322011
Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse
M Levis, F Ravandi, ES Wang, MR Baer, A Perl, S Coutre, H Erba, ...
Blood, The Journal of the American Society of Hematology 117 (12), 3294-3301, 2011
4072011
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually
JR Passweg, H Baldomero, P Bader, C Bonini, S Cesaro, P Dreger, ...
Bone marrow transplantation 51 (6), 786-792, 2016
4042016
The system can't perform the operation now. Try again later.
Articles 1–20